INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/17/2025
Back to search
Official data from USPTO
ALGIPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/18/2025
Trademark type
Word
Nice classes
5
Filing date
09/12/2016
Registration date
11/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2024
Last transaction
05/18/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
N-1337 Sandvika, NO
Examiner
MIDDLETON,BERNICE L
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
A. A. (pessoa física)
Representatives
ZACCO NORWAY AS
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparation for the treatment and prevention of microbial biofilm infectionsto normalize stagnant and viscous mucus for the treatment of pulmonary diseasescystic fibrosis and COPDmedical preparations for the treatment of infected wounds and ulcersveterinary preparations for biofilm infectionsmastitis and wounds
Publications
History of USPTO decisions and trademark events.
30 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/30/2025
INPC
INVALIDATION PROCESSED
04/30/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/07/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
02/14/2025
C71T
CANCELLED SECTION 71
06/14/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/04/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/15/2018
FIMP
FINAL DISPOSITION PROCESSED
03/15/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/28/2017
PUBO
PUBLISHED FOR OPPOSITION
09/12/2017
NPUB
NOTICE OF PUBLICATION
08/23/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/09/2017
CNEA
EXAMINERS AMENDMENT MAILED
08/04/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
08/03/2017
ALIE
ASSIGNED TO LIE
08/03/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/12/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/12/2017
RFNT
REFUSAL PROCESSED BY IB
02/03/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/13/2017
RFRR
REFUSAL PROCESSED BY MPU
01/13/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/05/2017
CNRT
NON-FINAL ACTION WRITTEN
01/04/2017
MAFR
APPLICATION FILING RECEIPT MAILED
12/31/2016
DOCK
ASSIGNED TO EXAMINER
12/27/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/27/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/22/2016
Continuous trademark protection
Get notified about every new filing that threatens ALGIPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.